Alnylam Pharmaceuticals
Heena Howitt is a seasoned medical professional with extensive experience in the pharmaceutical industry, currently serving as the UKIE Medical Director at Alnylam Pharmaceuticals since September 2023. Prior to this role, Heena spent 18 years at Takeda, ascending to the position of Country Medical Lead for Rare Genetics, Haematology, and Transplant, as well as for Genetic Diseases, alongside fulfilling the role of Medical Manager. Heena's earlier career includes positions as a Medical Advisor and Scientific Advisor, as well as experience in medical liaison and clinical data management at Sankyo Pharma UK and PAREXEL, respectively. Throughout the career, Heena has demonstrated leadership in medico-marketing across various therapy areas, including diabetes, renal, and rare gastrointestinal disorders.
This person is not in any teams
This person is not in any offices
Alnylam Pharmaceuticals
32 followers
Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market.